The results of Wang Ping supported the fact that, despite no significant difference in serum of E2, T, follicle stimulating hormone (FSH), and ovarian volume, CHF would be clinically useful, especially in patients with LH, LH/FSH, and basal AFC disturbances in PCOS [45]. This evidence concerns the gene PLOD1 and polycystic ovary syndrome.